Search
for
Sort by
Research 31–60 of 171
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Alopecia areata update
- The Skin in Pregnancy
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Trichoscopy in Hair Shaft Disorders
- Alternative uses of dermoscopy in daily clinical practice: An update
- Physiological Skin Changes During Pregnancy
- Congenital Triangular Alopecia (Brauer Nevus)
- Hair and Nail Relationship
- An Update on Drug-Induced Pigmentation
- Skin manifestations of chronic kidney disease
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Congenital atrichia and hypotrichosis
- Presence and future of dermoscopy
- Novel splice site mutation in the <i>LIPH</i> gene in a patient with autosomal recessive woolly hair/hypotrichosis: Case report and published work review
- Molecular Genetics of Alopecias
- Skin disorders associated with the COVID‐19 pandemic: A review
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Serum ferritin and vitamin D levels should be evaluated in patients with diffuse hair loss prior to treatment
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- Alterações dermatológicas em pacientes oncológicos – adultos e crianças
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- A case report of a novel, integrative approach to Hashimoto’s thyroiditis with unexpected results
- Cutaneous Reactions to Drugs
- Increase in IL-15 levels in patients with alopecia areata
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Spatial variation and associated genes of total hair follicle density in goats
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE